Dr. Anna Reustle
Scientist

Dr. Anna Reustle

Major Projects

  • Immunologic aspects of renal cell carcinoma
  • Omics analyses of clear cell renal cell carcinoma

Selected References

Reustle A.; Di Marco M.; Meyerhoff C.; Nelde A.; Walz J.S.; Winter S.; Kandabarau, S.; Büttner, F.; Haag, M.; Backert, L.; Kowalewski, D.; Rausch, S.; Hennenlotter, J.; Stühler, V.; Scharpf, M.; Fend, F.; Stenzl, A.; Rammensee, H.G.; Bedke, J.; Stevanović, S.; Schwab, M.; Schaeffeler, E. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome Med 2020, 12(394). doi:10.1186/s13073-020-00731-8

Reustle, A.; Fisel, P.; Renner, O.; Büttner, F.; Winter, S.; Rausch, S.; Kruck, S.; Nies, A.T.; Hennenlotter, J.; Scharpf, M.; Fend, F.; Stenzl, A.; Bedke, J.; Schwab, M.; Schaeffeler, E. Characterization of the Breast Cancer Resistance Protein (BCRP/ABCG2) in clear cell renal cell carcinoma. Int J Cancer 2018 143(12), 3181-3193, doi: 10.1002/ijc.31741.

Schaeffeler, E.; Büttner, F.; Reustle, A.; Klumpp, V.; Winter, S.; Rausch, S.; Fisel, P.; Hennenlotter, J.; Kruck, S.; Stenzl, A.; Warheit, J.; Sonntag, D.; Scharpf, M.; Fend, F.; Agaimy, A.; Hartmann, A.; Bedke, J.; Schwab, M. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin. Eur Urol Focus 2019, 5, 608–18. doi:10.1016/j.euf.2018.01.016

Büttner, F.; Winter, S.; Rausch, S.; Reustle, A.; Kruck, S.; Junker, K.; Stenzl, A.; Agaimy, A.; Hartmann, A.; Bedke, J.; Schwab, M.; Schaeffeler, E. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron. Eur Urol 2015, 68(6), 1016–1020, doi: 10.1016/j.eururo.2015.05.045

Curriculum Vitae

Education and Professional Career

Since 2018

Scientist at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Since 2018

Training as Clinical Chemist at the Robert-Bosch-Hospital

2014-2018

PhD Thesis at the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (Prof. Dr. M. Schwab); „Elucidation of underlying genomic, epigenomic and metabolomic factors contributing to the expression of candidate targets identified by HLA ligandome analysis in clear cell renal cell carcinoma“

2013-2014

Master thesis at the Department of Infectiology, Molecular Virology, University Hospital Heidelberg

2011

Bachelor thesis at the Department of Infectiology, Molecular Virology, University Hospital Heidelberg

2008-2014

Studies of Molecular Biotechnology at the Ruprecht-Karls University Heidelberg, Heidelberg, Germany